Get the Stockscreener App
44.08
0.36%
-0.16
After Hours:
44.16
0.08
+0.18%
Overview
News
Price History
Option Chain
Financials
Why AA Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $44.08, with a volume of 4.41M.
It is down -0.36% in the last 24 hours and down -18.52% over the past month.
Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is one of the world's largest bauxite miners and alumina refiners by production volume, but sits outside the top-10 aluminum producers, a list dominated by Chinese companies. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024.
See More
Previous Close:
$44.24
Open:
$44.24
24h Volume:
4.41M
Relative Volume:
0.83
Market Cap:
$11.63B
Revenue:
$14.00B
Net Income/Loss:
$1.26B
P/E Ratio:
9.0422
EPS:
4.8749
Net Cash Flow:
$352.00M
1W Performance:
+1.38%
1M Performance:
-18.52%
6M Performance:
-26.11%
1Y Performance:
+42.93%
1-Day Range:
$43.50
$44.66
1-Week Range:
$43.41
$47.03
52-Week Range:
$28.11
$84.38
Agilent Technologies Inc Stock (AA) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
412-315-2900
Address
201 ISABELLA STREET, PITTSBURGH, PA
Compare AA vs TMO, DHR, IDXX, A, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AA
Agilent Technologies Inc
|
44.08 | 11.67B | 14.00B | 1.26B | 352.00M | 4.8749 |
TMO
Thermo Fisher Scientific Inc
|
559.53 | 211.18B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.50 | 134.62B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
556.20 | 42.94B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
137.89 | 39.14B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
258.03 | 37.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
Agilent Technologies Inc Stock (AA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-13-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-27-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-13-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-08-26 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-08-25 | Initiated | Wells Fargo | Overweight |
| Jul-08-25 | Resumed | Citigroup | Buy |
| May-15-25 | Downgrade | UBS | Buy → Neutral |
| Apr-08-25 | Downgrade | BofA Securities | Buy → Underperform |
| Oct-23-24 | Upgrade | Argus | Hold → Buy |
| Oct-17-24 | Upgrade | B. Riley Securities | Neutral → Buy |
| Oct-01-24 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-25-24 | Resumed | JP Morgan | Neutral |
| Sep-04-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-12-24 | Upgrade | UBS | Sell → Buy |
| Aug-02-24 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-21-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-22-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-16-24 | Initiated | UBS | Sell |
| Dec-07-23 | Initiated | HSBC Securities | Hold |
| Oct-23-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-24-23 | Downgrade | Argus | Buy → Hold |
| Jul-14-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-11-23 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jun-22-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-11-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| May-08-23 | Initiated | JP Morgan | Overweight |
| Feb-22-23 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-23 | Reiterated | B. Riley Securities | Neutral |
| Dec-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-07-22 | Initiated | UBS | Neutral |
| Sep-22-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-16-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-08-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-24-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-11-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Nov-17-21 | Initiated | Wolfe Research | Outperform |
| Nov-02-21 | Upgrade | Jefferies | Hold → Buy |
| Oct-05-21 | Reiterated | JP Morgan | Overweight |
| Sep-29-21 | Reiterated | Morgan Stanley | Overweight |
| Sep-15-21 | Upgrade | Argus | Hold → Buy |
| Jul-16-21 | Upgrade | Citigroup | Neutral → Buy |
| Apr-23-21 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-17-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-03-21 | Upgrade | Goldman | Sell → Buy |
| Sep-08-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-16-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Mar-24-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Mar-04-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-17-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Dec-17-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Nov-13-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Nov-12-19 | Reiterated | B. Riley FBR | Buy |
| Nov-07-19 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-21-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Sep-26-19 | Reiterated | B. Riley FBR | Buy |
| Sep-23-19 | Downgrade | Goldman | Buy → Neutral |
| Sep-11-19 | Upgrade | Credit Suisse | Neutral → Outperform |
| Aug-16-19 | Reiterated | BofA/Merrill | Neutral |
| Jul-19-19 | Downgrade | Argus | Buy → Hold |
| Jul-11-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-09-19 | Downgrade | Macquarie | Outperform → Neutral |
| Apr-22-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-03-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Apr-02-19 | Downgrade | Credit Suisse | Outperform → Neutral |
View All
Agilent Technologies Inc Stock (AA) Latest News
Agilent Technologies Inc (A): GF Score of 94 Signals Strong Outp - GuruFocus
Agilent Technologies price driven lower by important resistanceForecast today27-07-2026 - Economies.com
Precision Trading with Agilent Technologies Inc. (A) Risk Zones - Stock Traders Daily
Agilent Technologies, Inc. (A) Stock Analysis: Exploring A 14.97% Upside Potential - DirectorsTalk Interviews
Agilent Technologies stock steadies as investors weigh recent earnings and life-science demand trend - Ad-hoc-news.de
A|Agilent Technologies Inc|Price:138.570|Chg%:-1.185 - TradingKey
Is Agilent Technologies (A) Undervalued Following Its FDA Approval For OPDIVO Companion Diagnostics? - Yahoo Finance UK
Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test - Yahoo Finance
Agilent Technologies Inc (A) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Agilent Technologies Inc (A) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Agilent Technologies Inc (A) Institutional Confidence - TradingKey
Agilent Technologies Inc (A) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
What to Expect From Agilent Technologies' Q3 2026 Earnings Report - inkl
A|Agilent Technologies Inc|Price:139.760|Chg%:+6.300 - TradingKey
Agilent Technologies Inc (A) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Agilent declares Q2 2026 distribution of R$ 0.44 per unit, payable July 28 - Bitget
A Look at Agilent Technologies Inc (A) After 4.7% Gain -- GF Val - GuruFocus
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Agilent Technologies (A) Secures EU Certification for Key Diagno - GuruFocus
Why Agilent Technologies Shares Are Rising Today - Quiver Quantitative
Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers - Moomoo
Agilent stock rises on EU approval for cancer diagnostic By Investing.com - Investing.com South Africa
Agilent stock rises on EU approval for cancer diagnostic - Investing.com
Agilent receives EU approval for ovarian cancer diagnostic test - Investing.com
Agilent receives EU approval for ovarian cancer diagnostic test By Investing.com - Investing.com South Africa
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma - Yahoo Finance
Agilent Technologies Inc (A) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Agilent BDR program executes 5-for-1 stock split on ratio adjustment - Bitget
A4881169 Bond Profile — Key Metrics - TradingView
Agilent Technologies (A) Stock Forecast & Analyst Ratings - Moomoo
Agilent stock holds near report levels as earnings metrics stay in view - Ad-hoc-news.de
Agilent Technologies (NYSE:A) Gains Fresh FDA Momentum - Kalkine Media
Agilent Technologies stock trades steady as life sciences demand supports revenue outlook - Ad-hoc-news.de
[Latest] Global Metal Stamping Market Size/Share Worth USD 412.6 Billion by 2035 at a 4.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Michael Buckner Joins Agilent Technologies as Chief Legal Officer - Medical Product Outsourcing
Agilent Technologies stock trades steadily as investors weigh recent earnings and life sciences dema - Ad-hoc-news.de
Agilent increases HALO X-ray Technologies stake - Airports International
HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited - marketscreener.com
Agilent Technologies (A) Stock Analysis: Unlocking a 21% Upside Potential with Robust Market Presence - DirectorsTalk Interviews
Agilent Technologies (A) Wells Fargo 20th Annual Healthcare Conference 2025 Summary - Quartr
Agilent Increases Its Investment in HALO X-ray Technologies - Morningstar
Agilent Technologies (A) Wins FDA Approval, Where Does Fair Value Sit Now? - Sahm
Agilent Technologies (A) Q2 2025 earnings summary - Quartr
Agilent Technologies (A) Q1 2026 earnings summary - Quartr
Agilent Technologies stock trades steady as recent earnings and life-science demand underpin valuati - Ad-hoc-news.de
Agilent Technologies (A) Citi Annual Global Healthcare Conference 2025 Summary - Quartr
Agilent Technologies (A) Proxy Filing Summary - Quartr
Agilent Technologies (A) Q4 2025 earnings summary - Quartr
Agilent Technologies stock holds support as results stay in focus - Ad-hoc-news.de
Agilent 1260 Infinity II LC by Agilent Technologies Inc.mid-range workhorse for routine labs - Ad-hoc-news.de
Agilent Technologies Inc (A) Stock Down 3.4% -- Now Undervalued? GF Score: 93/100 - GuruFocus
Agilent Technologies Inc Stock (AA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
2.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):